Advanced search: Search from
Select basic information for advanced search
| Free word |
|---|
| Details |  |
|---|---|
| Related links |  |
| Search |  |
Affiliation and department：
Research theme for competitive and other funds (2)：
Papers (21)：
MISC (1)：
Lectures and oral presentations (54)：
Return to Previous Page
外資系製薬企業
About 外資系製薬企業
Research theme for competitive and other funds (2)：
- 2020 - 2023 網膜ミクログリアの貪食能評価系の構築と新規網膜疾患予防・治療戦略確立への応用
- 2018 - 2020 神経-グリア-血管連関の破綻におけるMMPの意義の解明と新規緑内障治療薬への応用
- Asami Mori, Yuna Ezawa, Daiki Asano, Toshiki Kanamori, Akane Morita, Toshihide Kashihara, Kenji Sakamoto, Tsutomu Nakahara. Resveratrol dilates arterioles and protects against N-methyl-d-aspartic acid-induced excitotoxicity in the rat retina. Neuroscience letters. 2023. 793. 136999-136999
- Daiki Asano, Mihoka Kojima, Akane Morita, Tsutomu Nakahara. Tumor necrosis factor-α and matrix metalloproteinase-9 cooperatively exacerbate neurovascular degeneration in the neonatal rat retina. Cell and tissue research. 2022. 390. 2. 173-187
- Koki Nagaoka, Yuki Kurauchi, Daiki Asano, Akane Morita, Kenji Sakamoto, Tsutomu Nakahara. Pharmacological inhibition of Na+/K+-ATPase induces neurovascular degeneration and glial cell alteration in the rat retina. Experimental eye research. 2022. 220. 109107-109107
- Asami Mori, Daiki Sumida, Ryo Kondo, Ayuki Nakano, Shiho Arima, Daiki Asano, Akane Morita, Kenji Sakamoto, Tohru Nagamitsu, Tsutomu Nakahara. Impairment of endothelium-dependent vasodilator function of retinal blood vessels in adult rats with a history of retinopathy of prematurity. Journal of pharmacological sciences. 2021. 146. 4. 233-243
- Koki Watanabe, Daiki Asano, Hiroko Ushikubo, Akane Morita, Asami Mori, Kenji Sakamoto, Kunio Ishii, Tsutomu Nakahara. Metformin Protects against NMDA-Induced Retinal Injury through the MEK/ERK Signaling Pathway in Rats. International journal of molecular sciences. 2021. 22. 9
- 金森俊樹, 浅野大樹, 森田茜, 柏原俊英, 中原努. ラットにおけるNMDA誘発網膜神経傷害に対するAMPKを介したresveratrolの保護効果. 日本薬理学雑誌. 2022. 157. Supplement
-
Concomitant initiation of combination therapy with macitentan and tadalafil in pulmonary arterial hypertension (PAH) patients with comorbidities: Real-world data from OPUS and OrPHeUS
(The 9th Annual Meeting of the Japanese Pulmonary Circulation and Pulmonary Hypertension Society 2024) -
間質性肺疾患合併PHを対象とするポプラスタディの中間解析結果
(第9回日本肺高血圧・肺循環学会学術集会 2024) -
日本における肺高血圧症患者の診療実態調査
(第9回日本肺高血圧・肺循環学会学術集会 2024) -
Exploring treatment satisfaction between patients and doctors in PAH and CTEPH in Japan: A Survey-Based Study
(7th WORLD SYMPOSIUM ON PULMONARY HYPERTENSION 2024) -
間質性肺疾患合併肺高血圧症をターゲットとする前向きコホート研究-ポプラスタディの 中間解析結果
(第 131 回日本循環器学会北海道地方会 2024)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.
Return to Previous Page
